Benzonatate and Valcyte drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Benzonatate (benzonatate) and Valcyte (valganciclovir hydrochloride). Common drug interactions include chronic kidney disease among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Benzonatate and Valcyte. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Benzonatate?

Benzonatate has active ingredients of benzonatate. It is often used in cough. eHealthMe is studying from 17,274 Benzonatate users. Check the latest studies of Benzonatate.

What is Valcyte?

Valcyte has active ingredients of valganciclovir hydrochloride. It is often used in cmv - immunocompromised host. eHealthMe is studying from 6,409 Valcyte users. Check the latest studies of Valcyte.

On Jul, 12, 2026

21 people who take Benzonatate and Valcyte together, and have interactions are studied.

Benzonatate and Valcyte drug interactions.

What are the common drug interactions of Benzonatate and Valcyte, by gender? *:

female:

Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)
Back pain
Confusional state
Constipation
Diarrhoea
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Influenza

male:

Chronic kidney disease
Renal failure (kidney dysfunction)
Rash
Anaemia (lack of blood)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Asthenia (weakness)
Back pain
Blood albumin decreased
Blood glucose increased

What are the common drug interactions of Benzonatate and Valcyte, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Chronic kidney disease

30-39:

Chronic kidney disease
Depression
Renal failure (kidney dysfunction)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Bone disorder

40-49:

Chronic kidney disease
Renal failure (kidney dysfunction)
Anhedonia (inability to experience pleasure from activities usually found enjoyable)
Anxiety
Asthenia (weakness)
Back pain
Depression
Dysstasia (difficulty in standing)
Emotional distress
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

50-59:

Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
Renal impairment (severely reduced kidney function)
Glomerulonephritis membranous (nephritis with inflammation of the capillary loops in the renal glomeruli)
Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
Renal hypertension (high blood pressure caused by the kidneys hormonal response)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)
Chronic kidney disease
Nephrogenic anaemia (anaemia due to kidney disease)
Renal failure (kidney dysfunction)

60+:

Chronic kidney disease
Pain
Stress
Renal failure (kidney dysfunction)
Nephrogenic anaemia (anaemia due to kidney disease)
Renal injury (kidney injury)
Tubulointerstitial nephritis (a form of nephritis affecting the interstitium of the kidneys surrounding the tubules)

What are the existing conditions these people have? *

Pain: 14 people, 66.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 12 people, 57.14%
High Blood Pressure: 8 people, 38.10%
Indigestion: 6 people, 28.57%
Renal Disorder (kidney disease): 5 people, 23.81%
Liver Disorder (liver diseases): 5 people, 23.81%
Bacterial Infection: 5 people, 23.81%
Constipation: 5 people, 23.81%
Infection: 5 people, 23.81%
Hyperplasia (enlargement of an organ or tissue): 5 people, 23.81%

* Approximation only. Some reports may have incomplete information.

Do you take Benzonatate and Valcyte?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously